NEWPORT BEACH, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- NorthStrive Biosciences Inc. (“NorthStrive Biosciences”), a subsidiary of PMGC Holdings Inc. (NASDAQ:ELAB) (“PMGC”), today announced a progress update to the anticipated completion timeline for Phase III of its AI Development Program with strategic partner Yuva Biosciences, Inc. (“Yuva Biosciences”). On December 17, 2025, Northstrive Biosciences announced the initiation of Phase III, which was expected to last approximately 6 to 9 weeks. Northstive Bi ...

Core Insights - PMGC Holdings Inc. has completed the acquisition of SVM Machining, Inc., marking its third CNC machine shop acquisition in California, which aligns with its strategy to build a multi-site machining platform for various industries [1][3]. Company Overview - PMGC Holdings Inc. is a diversified holding company focused on managing and growing its portfolio through strategic acquisitions and investments across multiple sectors [7]. - SVM Machining, Inc. is an ISO 9001:2015 certified precision CNC machining company that serves critical industries such as medical, aerospace, biotech, semiconductor, and transportation [2][6]. Financial Details - The acquisition was completed on a cash-free, debt-free basis, with a base purchase price of $2,250,000, which includes $2,000,000 paid at closing and a $250,000 indemnification holdback [5][9]. - For the fiscal year ending December 31, 2024, SVM reported revenue of $3,042,701 [4]. Strategic Implications - The acquisition enhances PMGC's footprint in precision manufacturing and supports its growth strategy in sectors like aerospace, defense, medical, and industrial [3][6]. - SVM's expertise in delivering high-quality, engineered solutions positions PMGC to better serve original equipment manufacturers and advanced technology customers [6].

Core Insights - The consumer staples sector has several oversold stocks that present potential buying opportunities for undervalued companies [1] Group 1: Oversold Stocks - Oddity Tech Ltd (NASDAQ: ODD) has an RSI of 25.3, with a stock price decline of approximately 20% over the past month, closing at $33.80 [3][6] - PMGC Holdings Inc (NASDAQ: ELAB) has an RSI of 16.2, with a significant stock price drop of around 73% over the past month, closing at $3.56 [4][6] - Zevia Pbc (NYSE: ZVIA) has an RSI of 26, with a stock price decrease of about 33% over the past month, closing at $1.68 [5][6] Group 2: Analyst Ratings and Price Targets - Keybanc analyst maintained an Overweight rating for Oddity Tech, lowering the price target from $70 to $50 [6] - Telsey Advisory Group analyst maintained an Outperform rating for Zevia, keeping the price target at $6 [6]

Core Viewpoint - Premarket trading is showing significant activity with notable price movements indicating potential investment opportunities before the market opens [1] Premarket Gainers - Ventyx Biosciences, Inc. (VTYX) increased by 57% to $15.79 [3] - Cardio Diagnostics Holdings, Inc. (CDIO) rose by 36% to $4.02 [3] - Monte Rosa Therapeutics, Inc. (GLUE) saw a 28% increase to $20.54 [3] - Momentus Inc. (MNTS) gained 27% reaching $12.50 [3] - BioAge Labs, Inc. (BIOA) went up by 13% to $17.50 [3] - Neumora Therapeutics, Inc. (NMRA) increased by 11% to $2.03 [3] - Mobileye Global Inc. (MBLY) rose by 10% to $13.45 [3] - Society Pass Incorporated (SOPA) increased by 10% to $3.47 [3] - SU Group Holdings Limited (SUGP) saw an 8% rise to $6.32 [3] - Critical Metals Corp. (CRML) gained 7% reaching $12.73 [3] Premarket Losers - Evolution Metals & Technologies Corp. (EMAT) decreased by 28% to $15.20 [4] - Ascent Solar Technologies, Inc. (ASTI) fell by 12% to $4.65 [4] - Apogee Enterprises, Inc. (APOG) saw a 10% decline to $33.30 [4] - Next Technology Holding Inc. (NXTT) dropped by 8% to $8.49 [4] - AST SpaceMobile, Inc. (ASTS) decreased by 7% to $90.45 [4] - Nomadar Corp. (NOMA) fell by 7% to $3.66 [4] - EZGO Technologies Ltd. (EZGO) decreased by 7% to $1.99 [4] - Cohen & Company Inc. (COHN) saw a 6% decline to $28.30 [4] - PMGC Holdings Inc. (ELAB) dropped by 4% to $5.34 [4] - Anghami Inc. (ANGH) decreased by 3% to $4.49 [4]

Core Viewpoint - PMGC Holdings Inc. (NASDAQ:ELAB) has executed a reverse stock split to consolidate shares and potentially attract a broader investor base, aiming to stabilize its stock price and enhance market perception [1][5]. Group 1: Reverse Stock Split Details - The reverse stock split consolidates every four shares of common stock into one, effective January 6, 2026 [1][5]. - Shareholders will receive one full share for each fractional portion, ensuring no loss in value [2][5]. - The stock's CUSIP number has been adjusted to 73017P409, while the trading symbol remains unchanged [2]. Group 2: Stock Performance and Market Capitalization - ELAB's current stock price is $1.61, reflecting a 13.38% increase with a $0.19 change [3]. - The stock has fluctuated between $1.38 and $1.6195 on the day of reporting, with significant volatility over the past year, peaking at $398.86 and dropping to $1.38 [3]. - The market capitalization of ELAB is approximately $683 million, with a trading volume of 741,689 shares on the NASDAQ exchange [4].

Industry Overview - The U.S. small and micro modular reactor (SMR/MMR) market is experiencing rapid growth due to energy security needs, data center demand, and federal support for advanced nuclear technologies [1][2] - The global SMR market, including MMRs, is projected to grow from approximately $7.5 billion in 2025 to over $16 billion by 2034, representing a compound annual growth rate (CAGR) of about 9% [3] Company Investment - PMGC Holdings Inc. has announced that its investment arm, PMGC Capital LLC, has acquired non-controlling shares in Nuclea Energy Inc., which focuses on the development of Micro Modular Reactor (MMR) and advanced nuclear energy solutions [1] - This investment aligns with PMGC Capital's strategic focus on supporting companies within long-term growth trends, including next-generation energy infrastructure and decarbonization [2] Nuclea Energy Inc. Profile - Nuclea Energy aims to provide clean, reliable, and economically competitive nuclear energy by replacing high-cost fossil fuels with micro nuclear technology [4] - The company is developing its Morpheus micro reactor for commercial readiness, targeting off-grid applications such as remote communities and military infrastructure [4] PMGC Capital LLC Profile - PMGC Capital is a multi-strategy investment firm focused on direct investments, strategic lending, and acquiring undervalued companies across diverse markets [5] - The firm's mission is to identify high-potential opportunities to deliver sustainable growth and maximize returns on capital [5] PMGC Holdings Inc. Profile - PMGC Holdings Inc. is a diversified holding company that manages its portfolio through strategic acquisitions and investments across various industries [6] - The company is committed to exploring opportunities in multiple sectors to maximize growth and value [6]

Core Viewpoint - PMGC Holdings Inc. will implement a 1-for-4 reverse stock split effective January 6, 2026, which will reduce the number of outstanding shares while proportionally adjusting the share price [1]. Group 1: Reverse Stock Split Details - The reverse stock split will consolidate every 4 shares of issued and outstanding common stock into one share, resulting in approximately 503,713 shares outstanding post-split, down from approximately 2,014,852 shares [3]. - The trading symbol for the common stock will remain "ELAB," but a new CUSIP number 73017P409 will be assigned [5]. - Outstanding stock awards, options, and shares reserved for the equity incentive plan will be adjusted proportionally to reflect the reverse stock split [5]. Group 2: Impact on Shareholders - Shareholders entitled to fractional shares will receive one full share for each fractional portion [5]. - The reverse stock split does not affect the overall value of shareholder equity; it only reduces the number of shares outstanding while adjusting the share price accordingly [5].

Core Insights - PMGC Holdings Inc.'s subsidiary, AGA Precision Systems LLC, has achieved AS9100 certification, enhancing its position in the aerospace, defense, and space manufacturing sectors [1][2]. Group 1: Certification Impact - The AS9100 certification is a globally recognized quality management standard that validates AGA's structured, process-based quality management system, which is crucial for operational excellence and product reliability [2]. - With this certification, AGA is expected to strengthen relationships with existing customers and support more complex, regulated programs, potentially leading to increased demand and recurring work [3]. Group 2: Company Overview - AGA Precision Systems LLC specializes in high-tolerance CNC machining, serving sectors such as aerospace, defense, and space, and is known for delivering precision components to stringent technical specifications [5]. - Founded over a decade ago, AGA has built a strong reputation based on quality and reliability, growing its business primarily through referrals and repeat orders without a formal sales or marketing strategy [6]. Group 3: Strategic Initiatives - The company is exploring the integration of humanoid robotics and advanced robotic automation systems into its manufacturing processes as part of a long-term strategy aimed at enhancing operational excellence and next-generation manufacturing capabilities [4].

Core Viewpoint - NorthStrive Biosciences Inc. has initiated Phase III of its AI Development Program in collaboration with Yuva Biosciences, marking a significant advancement in developing therapies for obesity and related metabolic conditions [1][2]. Group 1: Phase III Development - Phase III aims to build on Phase II results, where YuvaBio utilized its MitoNova™ AI platform to identify small-molecule candidates that promote mitochondrial health and muscle preservation, particularly relevant for patients using GLP-1 receptor agonists [2][7]. - The Phase III program will generate biological data on AI-selected compounds, including cytotoxicity screening and ANT1 expression testing, and is expected to last approximately 6 to 9 weeks [2][7]. Group 2: Company Background - Yuva Biosciences, Inc. focuses on leveraging mitochondrial science and AI to develop therapeutic candidates targeting aging-related and metabolic pathways, utilizing its proprietary MitoNova™ platform [3]. - NorthStrive Biosciences Inc. specializes in developing aesthetic medicines, with its lead asset, EL-22, designed to address muscle preservation during weight loss treatments [4]. - PMGC Holdings Inc. is a diversified holding company managing a portfolio of subsidiaries, including NorthStrive Biosciences, and is committed to exploring growth opportunities across various sectors [5].

Core Insights - PMGC Holdings Inc. congratulates General Enterprise Ventures, Inc. on its uplisting to the NYSE American, marking a significant corporate milestone that enhances visibility and access to institutional capital [1][2] Company Overview - PMGC Holdings, through its subsidiary PMGC Capital, is an investor in General Enterprise Ventures, which focuses on environmentally safe fire-prevention technologies [2] - General Enterprise Ventures owns the CitroTech family of innovative fire prevention solutions, recognized for its effectiveness and environmental safety [10] Market Dynamics - The global fire prevention and suppression industry is expanding, driven by increasing demand for safer and environmentally sustainable technologies [3] - The CitroTech products are strategically positioned to benefit from this market expansion by providing non-toxic, rapidly deployable fire-inhibition solutions [3] Product Certifications and Accreditations - CitroTech is the only fire inhibitor recognized under the U.S. EPA's Safer Choice program, ensuring it meets stringent safety criteria [5] - The technology has received UL GreenGuard Gold certification, indicating its safety for volatile organic compounds (VOCs) [8] Strategic Focus - PMGC Capital's investment in GEVI aligns with its strategy of financing innovation in essential industries with substantial global growth potential [9] - The company targets multiple high-value markets, including industrial infrastructure, wildfire mitigation, and energy storage systems, driven by stricter regulations and increased safety standards [7][9] Innovation and Growth Potential - CitroTech boasts over 80 global patents and 18 environmental accreditations, supporting its long-term growth and market expansion [8][10] - The company's recurring-revenue model and scalable approach further enhance its potential for meaningful long-term growth and value creation [10]